chr4-93331209-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001510.4(GRID2):​c.1246-64398G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.617 in 148,332 control chromosomes in the GnomAD database, including 28,231 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 28231 hom., cov: 24)

Consequence

GRID2
NM_001510.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.148
Variant links:
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.712 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GRID2NM_001510.4 linkuse as main transcriptc.1246-64398G>A intron_variant ENST00000282020.9 NP_001501.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GRID2ENST00000282020.9 linkuse as main transcriptc.1246-64398G>A intron_variant 1 NM_001510.4 ENSP00000282020 P1O43424-1
GRID2ENST00000510992.5 linkuse as main transcriptc.961-64398G>A intron_variant 1 ENSP00000421257 O43424-2
GRID2ENST00000611049.4 linkuse as main transcriptc.1003-64398G>A intron_variant 1 ENSP00000483084

Frequencies

GnomAD3 genomes
AF:
0.617
AC:
91523
AN:
148224
Hom.:
28225
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.691
Gnomad AMI
AF:
0.599
Gnomad AMR
AF:
0.560
Gnomad ASJ
AF:
0.522
Gnomad EAS
AF:
0.731
Gnomad SAS
AF:
0.597
Gnomad FIN
AF:
0.647
Gnomad MID
AF:
0.546
Gnomad NFE
AF:
0.581
Gnomad OTH
AF:
0.595
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.617
AC:
91558
AN:
148332
Hom.:
28231
Cov.:
24
AF XY:
0.618
AC XY:
44611
AN XY:
72136
show subpopulations
Gnomad4 AFR
AF:
0.690
Gnomad4 AMR
AF:
0.560
Gnomad4 ASJ
AF:
0.522
Gnomad4 EAS
AF:
0.731
Gnomad4 SAS
AF:
0.596
Gnomad4 FIN
AF:
0.647
Gnomad4 NFE
AF:
0.581
Gnomad4 OTH
AF:
0.595
Alfa
AF:
0.579
Hom.:
33903
Bravo
AF:
0.608
Asia WGS
AF:
0.665
AC:
2315
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.47
DANN
Benign
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1433666; hg19: chr4-94252360; API